We explore the rise of antibiotic resistant bacteria and how to keep safe from “superbugs,” discover how nanotechnology looks promising in treating late-stage sepsis and why mapping human antibodies can lead to breakthroughs in combating disease.
Antibiotic Resistant Bacteria
Dr. Thomas Wittum, professor and chair of Veterinary Preventive Medicine at The Ohio State University’s College of Veterinary Medicine discusses his work in identifying antibiotic resistant bacteria in rivers. Wittum’s groundbreaking research has found antibiotic resistant bacteria at a U.S. Livestock Farm.
Then, Dr. Emily Feyes, the director of Ohio State University’s Veterinary Medical Center Antimicrobial Stewardship Program, discusses ways to keep people and animals safe from drug resistant bacteria and how educating future veterinarians and pet owners is the key to decreasing drug resistant “superbugs” in the future.
Take A Deeper Dive: Leading The Way Toward Safe, Effective Antibiotic Use
Bacteria Superbugs
Dr. Frederic Bertley talks about bacteria, what it is, and why the human body needs it to function.
Nanotechnology in Combating Sepsis
According to the CDC, 270,000 people die annually from sepsis. But there’s new research that gives us hope. Dr. Yizhou Dong, associate professor of Pharmaceutics and Pharmacology at Ohio State University found a way to use nanotechnology, the science of engineering cells, to treat late-stage sepsis.
Take A Deeper Dive: Finding A New Way To Fight Late-stage Sepsis
Nanotechnology In Medicine And Oceans
Dr. Frederic Bertley takes a look at some of the current uses of nanotechnology, from pregnancy tests to efforts in cleaning up the ocean’s plastic pollution.
Mapping Antibodies
Antibodies are immune proteins that recognize and attach to invasive pathogens, like viruses, bacteria, and parasites, which can come into our bodies. Humans have millions of antibodies and some scientists believe that the key to advancing medicine will be found in mapping all of our antibodies.
Dr. Robert Carnahan, the associate director for the Vanderbilt Vaccine Center, and his colleagues are looking at antibodies created in patients who have recovered from COVID-19 to both aid in developing therapies for the disease and to help inform vaccine development.
QED with Dr. B, is a fun and informative science series, co-produced by WOSU Public Media and COSI, that talks one-on-one with the scientists, engineers and innovators who are redefining how we interact with our world. Watch the series online or on WOSU TV on Wednesdays at 7:30 p.m.